Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/S0140-6736(21)00439-6 http://scihub22266oqcxt.onion/10.1016/S0140-6736(21)00439-6 34217425!8248927!34217425     free     free     free       Lancet 2021 ; 398 (10300): 622-637 Nephropedia Template TP {{tp|p=34217425|t=2021. Acute respiratory distress syndrome |pdf=|usr=}}{{34217425}} gab.com Text Acute respiratory distress syndrome JO: Lancet http://www.kidney.de/pget.php?&tw=1&pmid=34217425 #FOAvip Acute respiratory distress syndrome (ARDS) is an acute respiratory illness characterised by bilateral chest radiographical opacities with severe hypoxaemia due to non-cardiogenic pulmonary oedema. The COVID-19 pandemic has caused an increase in ARDS and highlighted challenges associated with this syndrome, including its unacceptably high mortality and the lack of effective pharmacotherapy. In this Seminar, we summarise current knowledge regarding ARDS epidemiology and risk factors, differential diagnosis, and evidence-based clinical management of both mechanical ventilation and supportive care, and discuss areas of controversy and ongoing research. Although the Seminar focuses on ARDS due to any cause, we also consider commonalities and distinctions of COVID-19-associated ARDS compared with ARDS from other causes. Twit Text FOAVip Acute respiratory distress syndrome ????Lancet http://www.kidney.de/pget.php?&tw=1&pmid=34217425 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34217425 #FOAvip English Wikipedia <ref>{{Cite pmid|34217425}}</ref> Acute respiratory distress syndrome #MMPMID34217425 Meyer NJ; Gattinoni L; Calfee CS Lancet 2021[Aug]; 398 (10300): 622-637 PMID34217425show ga Acute respiratory distress syndrome (ARDS) is an acute respiratory illness characterised by bilateral chest radiographical opacities with severe hypoxaemia due to non-cardiogenic pulmonary oedema. The COVID-19 pandemic has caused an increase in ARDS and highlighted challenges associated with this syndrome, including its unacceptably high mortality and the lack of effective pharmacotherapy. In this Seminar, we summarise current knowledge regarding ARDS epidemiology and risk factors, differential diagnosis, and evidence-based clinical management of both mechanical ventilation and supportive care, and discuss areas of controversy and ongoing research. Although the Seminar focuses on ARDS due to any cause, we also consider commonalities and distinctions of COVID-19-associated ARDS compared with ARDS from other causes. |COVID-19/epidemiology/therapy[MESH] |Humans[MESH] |Pandemics[MESH] |Respiration, Artificial/*methods[MESH] |Respiratory Distress Syndrome/diagnostic imaging/etiology/*physiopathology/*therapy[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH] |Tomography, X-Ray Computed[MESH]Acute respiratory distress syndrome (epmc).pdf DeepDyve Pubget Overpricing